ArticleMedicine2020

Phase 1 clinical study of cell therapy with effective-mononuclear cells (E-MNC) for radiogenic xerostomia (first-in-human study) (FIH study on E-MNC therapy for radiogenic xerostomia).

Yoshinori Sumita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.